SEC Form 4 · accession 0001127602-19-009281
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua Matthew Flum
Officer — EVP, Corp Strategy & Bus Dev
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | F | 990 | $57.83 | D | 14,946 | D | |
| Common StockF2 | Feb 28, 2019 | A | 1,268 | $57.83 | A | 16,214 | D | |
| Common Stock (restricted)F3 | Feb 28, 2019 | A | 2,297 | $57.83 | A | 17,768 | D | |
| Common Stock (pep) | holding | — | — | — | 2,616 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
- F2Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
- F3Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2020.